Leibniz research infrastructures of our partners
Driving Medical Innovation from Research to Patient Care
Leibniz Health Technologies accelerates the transfer of cutting-edge health technologies into clinical use through three specialized Leibniz research infrastructures. Together, they combine interdisciplinary research, clinical validation, and market-oriented development—making medical innovations ready for real-world application.
Competence Center Diabetes Karlsburg (KDK, Karlsburg)
Pioneering plasma medicine and advanced diagnostics, the KDK supports the development and clinical testing of medical technologies. With access to specialized patient cohorts, modern lab diagnostics, and strong hospital partnerships, it enables translational research under real healthcare conditions—advancing treatments for chronic wounds and diabetes.
Leibniz Joint Lab “First in Translation” (fiT, Aachen)
The fiT speeds up the journey from medical research to patient benefit. Specializing in bioactive materials, ATMPs (Advanced Therapy Medicinal Products), and 3D tissue models, it provides facilities for prototyping, feasibility studies, and regulatory preparation—helping innovators enter clinical trials faster.
Leibniz Center for Photonics in Infection Research (LPI, Jena)
Currently under development, the LPI will advance photonics-based technologies for diagnosing and treating infectious diseases. By integrating preclinical and clinical validation, it will accelerate the translation of light-based diagnostics and therapies from the lab to clinical practice.
Together, these infrastructures are the backbone of Leibniz Health Technologies’ translation strategy—linking top-tier research with clinical readiness and market potential, across technologies and applications.
Learn more about the LPI